# Cadila Pharmaceuticals Limited – FDA Inspection, May 3, 2018

Source: https://www.keypedia.com/records/fda_inspections/cadila-pharmaceuticals-limited/63f78d34-ad1d-4b85-87a0-067d7502a5cd
Source feed: FDA_Inspections

> FDA inspection 1052117 of Cadila Pharmaceuticals Limited, May 03, 2018. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1052117
- Company Name: Cadila Pharmaceuticals Limited
- Inspection Date: 2018-05-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1293740 - 2025-09-26
- FDA Inspection 1205061 - 2023-04-07
- FDA Inspection 1173461 - 2022-06-17
- FDA Inspection 1120482 - 2020-02-14
- [FDA Inspection 1019141 - 2017-07-14](https://www.keypedia.com/records/fda_inspections/cadila-pharmaceuticals-limited/e9b41269-ccf9-440a-998d-71b03bdd1872)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/linda-thai/f4d9a1c3-e5e8-4f13-8abe-e1f1e597c8f8)

Company: https://www.keypedia.com/companies/cadila-pharmaceuticals-limited/ea4ece29-89c9-42f3-9afa-58348dc605b9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c